---
title: "000739.SZ (000739.SZ) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/000739.SZ/news.md"
symbol: "000739.SZ"
name: "000739.SZ"
parent: "https://longbridge.com/zh-CN/quote/000739.SZ.md"
datetime: "2026-03-12T19:07:14.366Z"
locales:
  - [en](https://longbridge.com/en/quote/000739.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/000739.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/000739.SZ/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/000739.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/000739.SZ/news.md)


# 000739.SZ (000739.SZ) — 相关新闻

### [APELOA plans to launch a stock option incentive plan for 2026](https://longbridge.com/zh-CN/news/278550326.md)
*2026-03-10T12:28:14.000Z*
> APELOA released a draft of the 2026 stock option incentive plan, proposing to grant 7.597 million stock options, account

### ["Zero Revenue" attempts to break into the Beijing Stock Exchange but fails, Puqi Pharmaceutical indeed goes all in for a rapid H-share IPO](https://longbridge.com/zh-CN/news/274016732.md)
*2026-01-28T16:08:03.000Z*
> After failing to list on the Beijing Stock Exchange, Puqi Pharmaceutical quickly turned to the Hong Kong Stock Exchange 

### [APELOA: Long-term cooperation on CDMO projects with Derui Zhiya](https://longbridge.com/zh-CN/news/273823316.md)
*2026-01-27T09:50:25.000Z*
> APELOA announced that the company has recently signed a "Strategic Cooperation Framework Agreement" with Hangzhou Derui 

### [APELOA: The concerted parties of the controlling shareholder increased their holdings and announced subsequent increase plans](https://longbridge.com/zh-CN/news/272401991.md)
*2026-01-13T11:21:41.000Z*
> APELOA announced that its controlling shareholder's concerted actor, Yushan Sports, increased its holdings by 1.6535 mil

### [APELOA signed a strategic cooperation framework agreement with Xi'an Xintong](https://longbridge.com/zh-CN/news/271622628.md)
*2026-01-06T08:29:02.000Z*
> APELOA signed a strategic cooperation framework agreement with Xi'an Xintong Pharmaceutical Research Co., Ltd., and both

### [Overview of A-share Stock Buybacks: 16 Companies Disclose Buyback Progress](https://longbridge.com/zh-CN/news/270755828.md)
*2025-12-24T23:38:36.000Z*
> On December 25th, 16 companies announced their stock repurchase progress. 1 company proposed a repurchase, 2 companies d

### [APELOA: As of the 22nd, the repurchased shares reached 12.55 million, accounting for 1.08%](https://longbridge.com/zh-CN/news/270710555.md)
*2025-12-24T09:31:04.000Z*
> APELOA announced that as of December 22, the company has repurchased 12.55 million shares, accounting for 1.08% of the t

### [Apeloa Pharmaceutical Gets Regulatory Nod for Antiviral Drug](https://longbridge.com/zh-CN/news/270687121.md)
*2025-12-24T04:18:35.000Z*
> Apeloa Pharmaceutical Gets Regulatory Nod for Antiviral Drug

### [APELOA: Oseltamivir Phosphate Dry Suspension has obtained a drug registration certificate](https://longbridge.com/zh-CN/news/270588159.md)
*2025-12-23T08:20:06.000Z*
> APELOA announced that its holding subsidiary, Zhejiang Puluo Kangyu Pharmaceutical Co., Ltd., has obtained the drug regi